CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 13 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,201,000 | -17.9% | 10,913,000 | 0.0% | 0.17% | -12.5% |
| Q4 2021 | $8,776,000 | -13.6% | 10,913,000 | -1.8% | 0.19% | -28.4% |
| Q3 2021 | $10,154,000 | +30.0% | 11,113,000 | +48.8% | 0.27% | +23.5% |
| Q2 2021 | $7,810,000 | +72.1% | 7,468,000 | +67.1% | 0.22% | +19.9% |
| Q1 2021 | $4,537,000 | -92.9% | 4,468,000 | -93.1% | 0.18% | -94.7% |
| Q3 2020 | $63,520,000 | – | 64,842,000 | – | 3.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 21,000,000 | $13,956,000 | 0.88% |
| ARISTEIA CAPITAL, L.L.C. | 15,150,000 | $11,306,000 | 0.20% |
| LMR Partners LLP | 13,099,000 | $9,986,000 | 0.17% |
| UBS OCONNOR LLC | 8,250,000 | $5,595,000,000 | 0.08% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,100,000 | $3,916,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 250,000 | $164,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,025,000 | $1,605,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |